<DOC>
	<DOC>NCT00715416</DOC>
	<brief_summary>The investigators evaluated whether primary implantation of a self-expanding nitinol stent yielded anatomical and clinical benefits superior to those afforded by percutaneous transluminal angioplasty with optional secondary stenting.</brief_summary>
	<brief_title>PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents</brief_title>
	<detailed_description />
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Intermittent Claudication</mesh_term>
	<criteria>symptomatic peripheral artery disease with severe intermittent claudication (Fontaine stage IIb) critical limb ischemia in patients with stenosis or occlusions originating in the SFA up to 25 cm length of stenosis/occlusion previous bypass surgery at the site of treatment history of intolerance of antiplatelet therapy adverse reaction to heparin bleeding diathesis creatinine &gt;2.5 mg/dL active bacterial infection allergy to contrast media previous stent placement at or immediately adjacent to the target lesion</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2006</verification_date>
	<keyword>peripheral vascular diseases</keyword>
	<keyword>Intermittent Claudication</keyword>
	<keyword>Angioplasty</keyword>
</DOC>